ZA828517B - Haemophilus influenzae type b and pertussis outer membrane component combined vaccine - Google Patents

Haemophilus influenzae type b and pertussis outer membrane component combined vaccine

Info

Publication number
ZA828517B
ZA828517B ZA828517A ZA828517A ZA828517B ZA 828517 B ZA828517 B ZA 828517B ZA 828517 A ZA828517 A ZA 828517A ZA 828517 A ZA828517 A ZA 828517A ZA 828517 B ZA828517 B ZA 828517B
Authority
ZA
South Africa
Prior art keywords
outer membrane
haemophilus influenzae
membrane component
influenzae type
combined vaccine
Prior art date
Application number
ZA828517A
Other languages
English (en)
Inventor
Joseph S C Kuo
Nobuo Monji
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA828517B publication Critical patent/ZA828517B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA828517A 1981-11-19 1982-11-18 Haemophilus influenzae type b and pertussis outer membrane component combined vaccine ZA828517B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/323,523 US4474758A (en) 1981-11-19 1981-11-19 Haemophilus influenzae type b and pertussis outer membrane component combined vaccine

Publications (1)

Publication Number Publication Date
ZA828517B true ZA828517B (en) 1983-09-28

Family

ID=23259565

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA828517A ZA828517B (en) 1981-11-19 1982-11-18 Haemophilus influenzae type b and pertussis outer membrane component combined vaccine

Country Status (13)

Country Link
US (1) US4474758A (xx)
EP (1) EP0080021B1 (xx)
JP (1) JPS5892618A (xx)
AR (1) AR229929A1 (xx)
AU (1) AU554028B2 (xx)
CA (1) CA1192840A (xx)
DE (1) DE3269381D1 (xx)
DK (1) DK514882A (xx)
ES (1) ES8401722A1 (xx)
MX (1) MX7197E (xx)
NZ (1) NZ202483A (xx)
PH (1) PH18773A (xx)
ZA (1) ZA828517B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5300632A (en) * 1986-11-18 1994-04-05 Research Foundation Of State University Of New York Method for purifying an outer membrane protein of Haemophilus influenzae
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5019502A (en) * 1989-06-12 1991-05-28 Merck & Company, Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5039610A (en) * 1989-06-12 1991-08-13 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5045456A (en) * 1989-06-12 1991-09-03 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
EP0471177B1 (en) * 1990-08-13 1995-10-04 American Cyanamid Company Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
EP0471954A3 (en) * 1990-08-13 1993-03-03 American Cyanamid Company Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide
US7704959B2 (en) 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
IL24946A (en) * 1965-01-19 1969-05-28 Merck & Co Inc Process for preparing antibodies in cilus pertussis
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4196192A (en) * 1977-10-28 1980-04-01 American Cyanamid Company Combined Haemophilus influenzae type b and pertussis vaccine

Also Published As

Publication number Publication date
ES517524A0 (es) 1984-01-01
PH18773A (en) 1985-09-25
AU554028B2 (en) 1986-08-07
DE3269381D1 (en) 1986-04-03
US4474758A (en) 1984-10-02
CA1192840A (en) 1985-09-03
EP0080021B1 (en) 1986-02-26
EP0080021A3 (en) 1983-11-16
MX7197E (es) 1987-12-23
EP0080021A2 (en) 1983-06-01
ES8401722A1 (es) 1984-01-01
AU9071482A (en) 1983-05-26
DK514882A (da) 1983-05-20
NZ202483A (en) 1986-03-14
AR229929A1 (es) 1984-01-31
JPS5892618A (ja) 1983-06-02

Similar Documents

Publication Publication Date Title
GB2108097B (en) Improved pigments and their preparation
IL70727A0 (en) Coupled h.influenzae type b vaccine
JPS57205564A (en) Padding matirial and method
GB2108098B (en) Improved pigments and their preparation
JPS57118794A (en) Imunosome and preparation thereof
IL67022A (en) 2-halo-3-chloro-5-haloalkylpyridines and process for their preparation
IL66449A (en) Bis-amino compounds and their preparation
CY1522A (en) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols preparation and uses
DE3269381D1 (en) Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
IL65381A0 (en) Semipermeable membrane and its preparation
DE3260947D1 (en) Hydroquinones and their preparation
MW1681A1 (en) 2-nitroimidazoles and preparation thereof
DE3272416D1 (en) Improved polyvinyl chloride and preparation thereof
PH15882A (en) Combined haemophilus influenzae type b and pertussis vaccine
DE3264841D1 (en) 4-chloro-4-chloromethyloxetan-2-one and process for its preparation
ZA859297B (en) Process and vaccine
IL65920A0 (en) Vaccine and its preparation
DE3271515D1 (en) Improved polyvinyl chloride and preparation thereof
DE3163316D1 (en) Diacyloxyalkadienes and their preparation
AR243249A1 (es) Procedimiento para obtener derivados de acidos ¡oxo-4-4h-(1)-benzopiran-8-il¿alcanoicos, intermediarios de aplicacion exclusiva a dicho procedimiento y proceso para prepararlos.
GB2065651B (en) Substituted-phenylpyridines and preparation
JPS57188285A (en) Padding and production thereof
IL75834A (en) Pyrimidinylcarbinols and their preparation
IL75834A0 (en) Pyrimidinylcarbinols and their preparation
IL73203A (en) Benzyloxyalkyl-2-halopropionates and their preparation